Your browser doesn't support javascript.
loading
Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.
Winnenburg, Rainer; Sorbello, Alfred; Ripple, Anna; Harpaz, Rave; Tonning, Joseph; Szarfman, Ana; Francis, Henry; Bodenreider, Olivier.
Afiliação
  • Winnenburg R; Lister Hill National Center for Biomedical Communications, U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894, USA.
  • Sorbello A; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
  • Ripple A; Lister Hill National Center for Biomedical Communications, U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894, USA.
  • Harpaz R; Oracle Health Sciences GBU, 100 Crosby Drive, Bedford, MA 01730, USA.
  • Tonning J; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
  • Szarfman A; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
  • Francis H; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
  • Bodenreider O; Lister Hill National Center for Biomedical Communications, U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894, USA. Electronic address: olivier.bodenreider@nih.gov.
J Biomed Inform ; 57: 425-35, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26342964
ABSTRACT

BACKGROUND:

Traditional approaches to pharmacovigilance center on the signal detection from spontaneous reports, e.g., the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS). In order to enrich the scientific evidence and enhance the detection of emerging adverse drug events that can lead to unintended harmful outcomes, pharmacovigilance activities need to evolve to encompass novel complementary data streams, for example the biomedical literature available through MEDLINE.

OBJECTIVES:

(1) To review how the characteristics of MEDLINE indexing influence the identification of adverse drug events (ADEs); (2) to leverage this knowledge to inform the design of a system for extracting ADEs from MEDLINE indexing; and (3) to assess the specific contribution of some characteristics of MEDLINE indexing to the performance of this system.

METHODS:

We analyze the characteristics of MEDLINE indexing. We integrate three specific characteristics into the design of a system for extracting ADEs from MEDLINE indexing. We experimentally assess the specific contribution of these characteristics over a baseline system based on co-occurrence between drug descriptors qualified by adverse effects and disease descriptors qualified by chemically induced.

RESULTS:

Our system extracted 405,300 ADEs from 366,120 MEDLINE articles. The baseline system accounts for 297,093 ADEs (73%). 85,318 ADEs (21%) can be extracted only after integrating specific pre-coordinated MeSH descriptors and additional qualifiers. 22,889 ADEs (6%) can be extracted only after considering indirect links between the drug of interest and the descriptor that bears the ADE context.

CONCLUSIONS:

In this paper, we demonstrate significant improvement over a baseline approach to identifying ADEs from MEDLINE indexing, which mitigates some of the inherent limitations of MEDLINE indexing for pharmacovigilance. ADEs extracted from MEDLINE indexing are complementary to, not a replacement for, other sources.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MEDLINE / Medical Subject Headings / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Farmacovigilância Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MEDLINE / Medical Subject Headings / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Farmacovigilância Idioma: En Ano de publicação: 2015 Tipo de documento: Article